Phase III IGRT and SBRT versus IGRT and Hypofranctionated IMRT for Localized Intermediate Risk Prostate Cancer
Requires RT credentialing prior to patient registration. MBMC approved.
- MBMC, Brandi Koziatek, 314-996-5898
View More Information - This link will take you to clinicaltrials.gov for specific study information including eligibility criteria. A full list of participating institutions can also be found on this page.